Search Results 641-650 of 18555 for Relapse
Giving ixazomib citrate in addition to pomalidomide, dexamethasone, and stem cell transplantation may work better in treating patients with relapsed or ...
... Relapsed or Refractory NHL. The trial will be conducted in 2 parts: an initial Dose Escalation Phase (Part A) of CA-4948 in patients with Relapsed or ...
The purpose of this study is to determine the proper criteria for diagnosis of IgG4-related disease (IgG4-RD), identify strategies to avoid relapse and identify ...
Root Cause of Multiple Myeloma Relapse Revealed. Dana Sparks. September 18, 2013. Cancer. Mayo Clinic Receives $8.8 Million Federal Grant for Metabolomics ...
... relapse in participants of this new study. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous ...
Science Saturday: Genetic test solves mystery of family bleeding disorder featured image · Study shows drug reduces risk of relapse with neuromyelitis optica ...
Clinical trials · A Study to Evaluate APG2575 Combined with Novel Therapeutic Regimens To Treat Subjects with Relapsed or Refractory Multiple Myeloma and ...
Study shows drug reduces risk of relapse with neuromyelitis optica featured image. Featured News. Study shows drug reduces risk of relapse with neuromyelitis ...
Obinutuzumab With or Without PI3K-delta Inhibitor TGR-1202, Lenalidomide, or Combination Chemotherapy in Treating Patients With Relapsed or Refractory Grade I- ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.